Amedisys Overview
Amedisys Target Price
Analysts' 12-month price predictions for AMED.
Share Price
$95.4
Average Target Price
$100.00
4.8% upside
4.8% upside1 analysts in the last 4 months
High: $100 | Low: $100
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-03-25 | RBC CapitalFrank Morgan | $100 | 4.8% upside |  |
| 2023-07-06 | JefferiesBrian Tanquilut | $90.8 |  4.8% downside | |
| 2023-01-05 | Leerink Partners | $85 | 10.9% downside | |
| 2022-11-11 | Stephens | $106 | 11.1% upside | |
| 2022-07-26 | Truist FinancialDavid MacDonald | $150 | 57.2% upside | |
| 2022-07-03 | Deutsche BankJustin Bowers | $175 | 83.4% upside | |
| 2022-04-29 | Credit Suisse | $182 | 90.8% upside | |
| 2022-04-29 | Raymond James | $180 | 88.7% upside | |
| 2022-04-29 | Leerink Partners | $131 | 37.3% upside | |
| 2022-02-25 | BMO CapitalMatthew Borsch | $190 | 99.2% upside | |
| 2022-02-25 | RBC CapitalBen Hendrix | $199 | 108.6% upside | |
| 2022-02-24 | Deutsche BankJustin Bowers | $230 | 141.1% upside | |
| 2022-02-24 | Benchmark Co.Bill Sutherland | $175 | 83.4% upside | |
| 2021-11-04 | StephensScott Fidel | $185 | 93.9% upside | |